FDA Approves Wegovy Weight-Loss Pill
US$ 20.33
tirzepatide 60mg Tirzepatide - Vitality Research
Description
Specifically, GLP-1 and GIP receptor agonists are peptides that significantly influence appetite suppression, stabilization of blood glucose levels, and have a profound impact on fat metabolism
These medications work primarily for diabetes management but offer the added benefit of cardiovascular protection
It has been studied in humans for over a decade
Synapse (PatSnap)
The Phase 2 trial tested doses from 0.5mg to 12mg, with 2mg as the standard starting dose for titration
